Merck & Co., Inc. Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Merck & Co., Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2016 to Q2 2024.
  • Merck & Co., Inc. Deferred Income Tax Liabilities, Net for the quarter ending June 30, 2024 was $876M, a 12% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $876M -$120M -12% Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $922M -$520M -36.1% Mar 31, 2024 10-Q 2024-05-03
Q4 2023 $871M -$924M -51.5% Dec 31, 2023 10-Q 2024-08-05
Q3 2023 $1.02B -$1.4B -57.9% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $996M -$1.98B -66.5% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $1.44B -$1.63B -53% Mar 31, 2023 10-Q 2023-05-05
Q4 2022 $1.8B -$1.65B -47.8% Dec 31, 2022 10-K 2024-02-26
Q3 2022 $2.42B +$890M +58.3% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $2.97B +$1.49B +99.7% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $3.07B +$1.87B +155% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $3.44B +$2.44B +242% Dec 31, 2021 10-K 2023-02-24
Q3 2021 $1.53B -$250M -14.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $1.49B -$602M -28.8% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $1.2B -$739M -38% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $1.01B -$465M -31.6% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $1.78B -$183M -9.34% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $2.09B +$2M +0.1% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $1.94B +$108M +5.89% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $1.47B -$232M -13.6% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $1.96B -$105M -5.09% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $2.09B -$70M -3.24% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 $1.84B -$371M -16.8% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $1.7B -$517M -23.3% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $2.07B Sep 30, 2018 10-Q 2018-11-06
Q2 2018 $2.16B Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $2.21B Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $2.22B -$2.86B -56.3% Dec 31, 2017 10-K 2019-02-27
Q4 2016 $5.08B Dec 31, 2016 10-K 2018-02-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.